{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:44:26Z","timestamp":1793979866703,"version":"4.8.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008484","name":"BioMarin Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008484","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009422","name":"National PKU Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009422","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["gimjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genetics in Medicine"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.gim.2024.101289","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T04:04:37Z","timestamp":1733285077000},"page":"101289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Phenylalanine hydroxylase deficiency diagnosis and management: A 2023 evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG)"],"prefix":"10.1016","volume":"27","author":[{"given":"Wendy E.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan A.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn","family":"Bloom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara K.","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia M.","family":"Demarest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle P.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Malinowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim L.","family":"McBride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Joel","family":"Mroczkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curt","family":"Scharfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Vockley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.gim.2024.101289_bib1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/ijns6030059","article-title":"The early history of PKU","volume":"6","author":"Woolf","year":"2020","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.gim.2024.101289_bib2","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1542\/peds.32.3.338","article-title":"A\u00a0simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants","volume":"32","author":"Guthrie","year":"1963","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.gim.2024.101289_bib3","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/jama.1961.03040470079019","article-title":"Blood screening for phenylketonuria","volume":"178","author":"Guthrie","year":"1961","journal-title":"JAMA"},{"issue":"6277","key":"10.1016\/j.gim.2024.101289_bib4","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1136\/bmj.282.6277.1680","article-title":"screening for phenylketonuria in the United Kingdom 1964-78. Medical Research Council Steering Committee for the MRC\/DHSS Phenylketonuria Register","volume":"282","year":"1981","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"4","key":"10.1016\/j.gim.2024.101289_bib5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.20517\/rdodj.2023.30","article-title":"The Australian landscape of newborn screening in the genomics era","volume":"2","author":"Ji","year":"2023","journal-title":"Rare Dis Orphan Drugs J"},{"issue":"3","key":"10.1016\/j.gim.2024.101289_bib6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/ijns4030028","article-title":"Reliability of neonatal screening results","volume":"4","author":"Knapkova","year":"2018","journal-title":"Int J Neonatal Screen"},{"issue":"3","key":"10.1016\/j.gim.2024.101289_bib7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/jech.53.3.179","article-title":"Secondary analysis of economic data: a review of cost-benefit studies of neonatal screening for phenylketonuria","volume":"53","author":"Lord","year":"1999","journal-title":"J\u00a0Epidemiol Community Health"},{"issue":"4","key":"10.1016\/j.gim.2024.101289_bib8","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/BF01797933","article-title":"Economic evaluation of cost-benefit ratio of neonatal screening procedure for phenylketonuria and hypothyroidism","volume":"14","author":"Dhondt","year":"1991","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"3","key":"10.1016\/j.gim.2024.101289_bib9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/ijns8030040","article-title":"Newborn screening by genomic sequencing: opportunities and challenges","volume":"8","author":"Bick","year":"2022","journal-title":"Int J Neonatal Screen"},{"issue":"2","key":"10.1016\/j.gim.2024.101289_bib10","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/gim.2013.157","article-title":"Phenylalanine hydroxylase deficiency: diagnosis and management guideline","volume":"16","author":"Vockley","year":"2014","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.gim.2024.101289_bib11","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13023-017-0685-2","article-title":"The complete European guidelines on phenylketonuria: diagnosis and treatment","volume":"12","author":"van Wegberg","year":"2017","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"10.1016\/j.gim.2024.101289_bib12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ymgme.2013.05.003","article-title":"The time consuming nature of phenylketonuria: a cross-sectional study investigating time burden and costs of phenylketonuria in the Netherlands","volume":"109","author":"Eijgelshoven","year":"2013","journal-title":"Mol Genet Metab"},{"issue":"3","key":"10.1016\/j.gim.2024.101289_bib13","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ymgme.2011.12.004","article-title":"Diet in phenylketonuria: a snapshot of special dietary costs and reimbursement systems in 10 international centers","volume":"105","author":"Belanger-Quintana","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.gim.2024.101289_bib14","first-page":"8","article-title":"Phenylketonuria (PKU): a problem solved?","volume":"6","author":"Brown","year":"2016","journal-title":"Mol Genet Metab Rep"},{"issue":"1","key":"10.1016\/j.gim.2024.101289_bib15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ymgme.2018.03.006","article-title":"Pegvaliase for the treatment of phenylketonuria: results of a long-term phase 3 clinical trial program (PRISM)","volume":"124","author":"Thomas","year":"2018","journal-title":"Mol Genet Metab"},{"issue":"9","key":"10.1016\/j.gim.2024.101289_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2022.12.005","article-title":"Phenylalanine hydroxylase deficiency treatment and management: a systematic evidence review of the American College of Medical Genetics and Genomics (ACMG)","volume":"25","author":"Adams","year":"2023","journal-title":"Genet Med"},{"key":"10.1016\/j.gim.2024.101289_bib18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jclinepi.2016.01.032","article-title":"GRADE guidelines: 16. GRADE evidence to decision frameworks for tests in clinical practice and public health","volume":"76","author":"Sch\u00fcnemann","year":"2016","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.gim.2024.101289_bib19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jclinepi.2016.07.006","article-title":"Guideline panels should seldom make good practice statements: guidance from the GRADE Working Group","volume":"80","author":"Guyatt","year":"2016","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"suppl 1","key":"10.1016\/j.gim.2024.101289_bib20","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/j.ymgme.2009.10.182","article-title":"Psychiatric symptoms and disorders in phenylketonuria","volume":"99","author":"Brumm","year":"2010","journal-title":"Mol Genet Metab"},{"issue":"suppl 2","key":"10.1016\/j.gim.2024.101289_bib21","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1007\/PL00014392","article-title":"Behaviour in early treated phenylketonuria: a systematic review","volume":"159","author":"Smith","year":"2000","journal-title":"Eur J Pediatr"},{"issue":"3","key":"10.1016\/j.gim.2024.101289_bib22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/jpepsy\/24.3.281","article-title":"Review: emotional and behavioral functioning in phenylketonuria","volume":"24","author":"Sullivan","year":"1999","journal-title":"J\u00a0Pediatr Psychol"},{"issue":"5","key":"10.1016\/j.gim.2024.101289_bib23","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/BF01799946","article-title":"Agoraphobia in phenylketonuria","volume":"14","author":"Waisbren","year":"1991","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"1","key":"10.1016\/j.gim.2024.101289_bib24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ymgme.2012.11.003","article-title":"A\u00a0diversified approach for PKU treatment: routine screening yields high incidence of psychiatric distress in phenylketonuria clinics","volume":"108","author":"Burton","year":"2013","journal-title":"Mol Genet Metab"},{"issue":"1","key":"10.1016\/j.gim.2024.101289_bib25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1046\/j.1365-2788.1999.43120176.x","article-title":"Economic impact of feeding a phenylalanine-restricted diet to adults with previously untreated phenylketonuria","volume":"43","author":"Brown","year":"1999","journal-title":"J\u00a0Intellect Disabil Res"},{"issue":"suppl 2","key":"10.1016\/j.gim.2024.101289_bib26","doi-asserted-by":"crossref","first-page":"S415","DOI":"10.1007\/s10545-008-0978-7","article-title":"Quality of life in noncompliant adults with phenylketonuria after resumption of the diet","volume":"31","author":"Bik-Multanowski","year":"2008","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"1","key":"10.1016\/j.gim.2024.101289_bib27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13023-020-01668-2","article-title":"The effect of improved dietary control on cognitive and psychiatric functioning in adults with phenylketonuria: the ReDAPT study","volume":"16","author":"Burgess","year":"2021","journal-title":"Orphanet J Rare Dis"},{"issue":"9","key":"10.1016\/j.gim.2024.101289_bib28","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.3390\/nu11092035","article-title":"Improved eating behaviour and nutrient intake in noncompliant patients with phenylketonuria after reintroducing a protein substitute: observations from a multicentre study","volume":"11","author":"Green","year":"2019","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.gim.2024.101289_bib29","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0022-3476(88)80320-2","article-title":"Behavior disturbance in 8-year-old children with early treated phenylketonuria. Report from the MRC\/DHSS phenylketonuria register","volume":"112","author":"Smith","year":"1988","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.gim.2024.101289_bib30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1477-7525-6-25","article-title":"Evaluation of quality of life and description of the sociodemographic state in adolescent and young adult patients with phenylketonuria (PKU)","volume":"6","author":"Simon","year":"2008","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"10.1016\/j.gim.2024.101289_bib31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10545-006-0433-6","article-title":"The course of life and quality of life of early and continuously treated Dutch patients with phenylketonuria","volume":"30","author":"Bosch","year":"2007","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"3","key":"10.1016\/j.gim.2024.101289_bib32","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0022-3476(87)80500-0","article-title":"New England Maternal PKU Project: prospective study of untreated and treated pregnancies and their outcomes","volume":"110","author":"Rohr","year":"1987","journal-title":"J\u00a0Pediatr"},{"issue":"3","key":"10.1016\/j.gim.2024.101289_bib33","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/(SICI)1096-9926(199603)53:3<176::AID-TERA5>3.0.CO;2-2","article-title":"Maternal phenylketonuria: a metabolic teratogen","volume":"53","author":"Levy","year":"1996","journal-title":"Teratology"},{"issue":"3","key":"10.1016\/j.gim.2024.101289_bib34","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/BF01811706","article-title":"Maternal PKU collaborative study: the effect of nutrient intake on pregnancy outcome","volume":"14","author":"Matalon","year":"1991","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.gim.2024.101289_bib35","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1749-6632.1993.tb26142.x","article-title":"The effect of nutrient intake on pregnancy outcome in maternal phenylketonuria","volume":"678","author":"Koch","year":"1993","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"10.1016\/j.gim.2024.101289_bib36","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1046\/j.1440-1754.2003.00174.x","article-title":"Maternal phenylketonuria in Western Australia: pregnancy outcomes and developmental outcomes in offspring","volume":"39","author":"Ng","year":"2003","journal-title":"J\u00a0Paediatr Child Health"},{"issue":"4","key":"10.1016\/j.gim.2024.101289_bib37","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ymgme.2012.09.027","article-title":"Congenital heart disease in maternal PKU","volume":"107","author":"Levy","year":"2012","journal-title":"Mol Genet Metab"},{"issue":"2","key":"10.1016\/j.gim.2024.101289_bib38","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ymgme.2014.02.013","article-title":"Phenylketonuria Scientific Review Conference: state of the science and future research needs","volume":"112","author":"Camp","year":"2014","journal-title":"Mol Genet Metab"},{"issue":"21","key":"10.1016\/j.gim.2024.101289_bib39","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1056\/NEJM198011203032104","article-title":"Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies","volume":"303","author":"Lenke","year":"1980","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.gim.2024.101289_bib40","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1186\/s13023-021-02108-5","article-title":"Preventing maternal phenylketonuria (PKU) syndrome: important factors to achieve good metabolic control throughout pregnancy","volume":"16","author":"Rohde","year":"2021","journal-title":"Orphanet J Rare Dis"},{"issue":"6 Pt 2","key":"10.1016\/j.gim.2024.101289_bib41","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1542\/peds.112.S4.1523","article-title":"The maternal phenylketonuria international study: 1984-2002","volume":"112","author":"Koch","year":"2003","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.gim.2024.101289_bib42","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/ajcn\/88.3.700","article-title":"Factors influencing outcomes in the offspring of mothers with phenylketonuria during pregnancy: the importance of variation in maternal blood phenylalanine","volume":"88","author":"Maillot","year":"2008","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1016\/j.gim.2024.101289_bib43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ymgme.2014.02.016","article-title":"Sapropterin dihydrochloride use in pregnant women with phenylketonuria: an interim report of the PKU MOMS sub-registry","volume":"112","author":"Grange","year":"2014","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.gim.2024.101289_bib46","article-title":"Continuation of pegvaliase treatment during pregnancy: a case report","volume":"26","author":"Boyer","year":"2021","journal-title":"Mol Genet Metab Rep"},{"issue":"3","key":"10.1016\/j.gim.2024.101289_bib48","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1089\/bfm.2013.0092","article-title":"Breastfeeding infants with phenylketonuria in the United States and Canada","volume":"9","author":"Banta-Wright","year":"2014","journal-title":"Breastfeed Med"},{"issue":"1","key":"10.1016\/j.gim.2024.101289_bib49","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.pedn.2014.05.003","article-title":"Challenges to breastfeeding infants with phenylketonuria","volume":"30","author":"Banta-Wright","year":"2015","journal-title":"J\u00a0Pediatr Nurs"},{"issue":"4","key":"10.1016\/j.gim.2024.101289_bib50","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1590\/S2179-64912012000400016","article-title":"Breastfeeding follow-up in the treatment of children with phenylketonuria","volume":"24","author":"Lam\u00f4nica","year":"2012","journal-title":"J\u00a0Soc Bras Fonoaudiol"},{"issue":"3","key":"10.1016\/j.gim.2024.101289_bib68","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3390\/nu11030529","article-title":"How does feeding development and progression onto solid foods in PKU compare with non-PKU children during weaning?","volume":"11","author":"Evans","year":"2019","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.gim.2024.101289_bib54","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ajhg.2020.06.006","article-title":"The genetic landscape and epidemiology of phenylketonuria","volume":"107","author":"Hillert","year":"2020","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1016\/j.gim.2024.101289_bib55","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/humu.10192","article-title":"Phenylketonuria mutations in Europe","volume":"21","author":"Zschocke","year":"2003","journal-title":"Hum Mutat"},{"issue":"11","key":"10.1016\/j.gim.2024.101289_bib51","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/humu.23649","article-title":"Unique aspects of sequence variant interpretation for inborn errors of metabolism (IEM): the ClinGen IEM Working Group and the phenylalanine hydroxylase gene","volume":"39","author":"Zastrow","year":"2018","journal-title":"Hum Mutat"},{"issue":"5","key":"10.1016\/j.gim.2024.101289_bib52","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.gim.2024.101289_bib56","series-title":"GeneReviews","article-title":"Phenylalanine hydroxylase deficiency","author":"Regier","year":"2000"},{"issue":"8","key":"10.1016\/j.gim.2024.101289_bib57","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/gim.2013.10","article-title":"Newborn screening 50 years later: access issues faced by adults with PKU","volume":"15","author":"Berry","year":"2013","journal-title":"Genet Med"},{"issue":"suppl 1","key":"10.1016\/j.gim.2024.101289_bib58","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ymgme.2009.10.005","article-title":"White matter pathology in phenylketonuria","volume":"99","author":"Anderson","year":"2010","journal-title":"Mol Genet Metab"},{"issue":"5","key":"10.1016\/j.gim.2024.101289_bib59","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s10545-011-9439-9","article-title":"Decreased functional brain connectivity in individuals with early-treated phenylketonuria: evidence from resting state fMRI","volume":"35","author":"Christ","year":"2012","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"4","key":"10.1016\/j.gim.2024.101289_bib60","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/87565641.2016.1243109","article-title":"Systematic review and meta-analysis of neuropsychiatric symptoms and executive functioning in adults with phenylketonuria","volume":"41","author":"Bilder","year":"2016","journal-title":"Dev Neuropsychol"},{"issue":"3","key":"10.1016\/j.gim.2024.101289_bib61","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ymgme.2018.09.006","article-title":"Prevalence of comorbid conditions among adult patients diagnosed with phenylketonuria","volume":"125","author":"Burton","year":"2018","journal-title":"Mol Genet Metab"},{"issue":"6","key":"10.1016\/j.gim.2024.101289_bib62","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s10545-010-9073-y","article-title":"The reality of dietary compliance in the management of phenylketonuria","volume":"33","author":"MacDonald","year":"2010","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"1-2","key":"10.1016\/j.gim.2024.101289_bib63","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ymgme.2007.05.006","article-title":"Phenylalanine blood levels and clinical outcomes in phenylketonuria: a systematic literature review and meta-analysis","volume":"92","author":"Waisbren","year":"2007","journal-title":"Mol Genet Metab"},{"issue":"3","key":"10.1016\/j.gim.2024.101289_bib64","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-2261","article-title":"Medical foods for inborn errors of metabolism: history, current status, and critical need","volume":"145","author":"Berry","year":"2020","journal-title":"Pediatrics"},{"key":"10.1016\/j.gim.2024.101289_bib65","article-title":"The financial and time burden associated with phenylketonuria treatment in the United States","volume":"21","author":"Rose","year":"2019","journal-title":"Mol Genet Metab Rep"},{"issue":"1","key":"10.1016\/j.gim.2024.101289_bib66","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12913-020-5054-5","article-title":"Prevalence, characteristics, and costs of diagnosed homocystinuria, elevated homocysteine, and phenylketonuria in the United States: a retrospective claims-based comparison","volume":"20","author":"Sellos-Moura","year":"2020","journal-title":"BMC Health Serv Res"},{"issue":"9750","key":"10.1016\/j.gim.2024.101289_bib67","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(10)60961-0","article-title":"Phenylketonuria","volume":"376","author":"Blau","year":"2010","journal-title":"Lancet"}],"updated-by":[{"DOI":"10.1016\/j.gim.2025.101602","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000}}],"container-title":["Genetics in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360024002235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360024002235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T01:04:48Z","timestamp":1767229488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098360024002235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1098360024002235"],"URL":"https:\/\/doi.org\/10.1016\/j.gim.2024.101289","relation":{},"ISSN":["1098-3600"],"issn-type":[{"value":"1098-3600","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenylalanine hydroxylase deficiency diagnosis and management: A 2023 evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG)","name":"articletitle","label":"Article Title"},{"value":"Genetics in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gim.2024.101289","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American College of Medical Genetics and Genomics. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101289"}}